The cotton rat model for adenovirus ocular infection: Antiviral activity of cidofovir

Antiviral Research

Volumn 61, Issue 1, 2004, Pages 63-66

  Kaneko, Hisatoshi ^a   Mori, Shuichi ^a   Suzuki, Osamu ^a   Iida, Tomohiro ^a   Shigeta, Shiro ^a   Abe, Masafumi ^a   Ohno, Shigeaki ^b   Aoki, Koki ^c   Suzutani, Tatsuo ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Aoki Eye Clinic   (Japan)

Author keywords

Adenoviral conjunctivitis; Adenovirus; Cidofovir; Cotton rat

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; CYTOSINE; DRUG DERIVATIVE; EYE DROPS; ORGANOPHOSPHORUS COMPOUND; VIRUS ANTIGEN;

ADENOVIRUS 5; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA EPITHELIUM; DISEASE MODEL; DRUG EFFECT; DRUG SCREENING; EPITHELIUM CELL; EXTRACTION; EYE INFECTION; FEMALE; GROWTH, DEVELOPMENT AND AGING; HOMOGENATE; HUMAN ADENOVIRUS; IMMUNOFLUORESCENCE; INOCULATION; KERATITIS; MURIDAE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTYPE; STATISTICAL SIGNIFICANCE; TOPICAL DRUG ADMINISTRATION; VIRAL CONJUNCTIVITIS; VIROLOGY; VIRUS CULTURE; VIRUS INFECTION; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TITRATION;

ADENOVIRIDAE; ANIMALIA; GOSSYPIUM HIRSUTUM; SIGMODON;

EID: 0345599229     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2003.08.003     Document Type: Article

References (13)

1. de Oliveira C.B., Stevenson D., LaBree L., McDonnell P.J., Trousdale M.D. Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antivir. Res. 31:1996;165-172.
2. Ford E., Nelson K.E., Warren D. Epidemiology of epidemic keratoconjunctivitis. Epidemiol. Rev. 9:1987;244-261.
3. Gordon Y.J., Romanowski E.G., Araullo-Cruz T.P., Seaberg L., Erzurum S., Tolman R., De Clercq E. Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2′-nor-cyclic-GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro. Antivir. Res. 16:1991;11-16.
4. Gordon Y.J., Romanowski E., Araullo-Cruz T. An ocular model of adenovirus type 5 infection in the NZ rabbit. Invest. Ophthalmol. Vis. Sci. 33:1992;574-580.
5. Gordon Y.J., Romanowski E.G., Araullo-Cruz T.P. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Invest. Ophthalmol. Vis. Sci. 35:1994;4135-4143.
6. Kaneko H., Kato K., Mori S., Shigeta S. Antiviral activity of NMSO3 against adenovirus in vitro. Antivir. Res. 52:2001;281-288.
7. Kodama E., Shigeta S., Suzuki T., De Clercq E. Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method. Antivir. Res. 31:1996;159-164.
8. Mentel R., Kinder M., Wegner U., von Janta-Lipinski M., Matthes E. Inhibitory activity of 3′-fluoro-2′ deoxythymidine and related nuculeoside analogues against adenoviruses in vitro. Antivir. Res. 34:1997;113-119.
9. Nagl M., Larcher C., Gottardi W. Activity of N-chlorotaurine against herpes simplex and adenoviruses. Antivir. Res. 38:1998;25-30.
10. Romanowski E.G., Araullo-Cruz T., Gordon Y.J. Multiple adenoviral serotypes demonstrate host range extension in the New Zealand rabbit ocular model. Invest. Ophthalmol. Vis. Sci. 39:1998;532-536.
11. Tsai J.C., Garlinghouse G., McDonnell P.J., Trousdale M.D. An experimental animal model of adenovirus-induced ocular disease. The cotton rat. Arch. Ophthalmol. 110:1992;1167-1170.
12. Trousdale M.D., Goldschmidt P.L., Nobrega R. Activity of ganciclovir against human adenovirus type-5 infection in cell culture and cotton rat eyes. Cornea. 13:1994;435-439.
13. Trousdale M.D., Nobrega R., Wood R.L., Stevenson D., dos Santos P.M., Klein D., McDonnell P.J. Studies of adenovirus-induced eye disease in the rabbit model. Invest. Ophthalmol. Vis. Sci. 36:1995;2740-2748.